Roth Capital Reiterates Buy on SkinHealth Systems, Lowers Price Target to $2
SkinHealth
SkinHealth SKIN | 0.00 |
Roth Capital analyst George Kelly reiterates SkinHealth Systems (NASDAQ:
SKIN) with a Buy and lowers the price target from $2.5 to $2.
